Literature DB >> 12707378

Novel fluorescent ligase detection reaction and flow cytometric analysis of SYT-SSX fusions in synovial sarcoma.

Robyn Gaffney1, Artemis Chakerian, John X O'Connell, Joan Mathers, Kelly Garner, Nancy Joste, David S Viswanatha.   

Abstract

Synovial sarcomas (SS) are characterized by the t(X;18)(p11;q11) translocation and its resultant fusion gene, SYT-SSX. Two homologues of the SSX gene (ie, SSX1 and SSX2) are involved in the vast majority of SS and the SYT-SSX1 type of fusion has been associated with inferior clinical outcome. Thus, detection of the presence and type of SYT-SSX fusion is critical for diagnosis and prognosis in SS. Identification of SYT-SSX fusion type is typically accomplished by reverse-transcription polymerase chain reaction (RT-PCR) followed by a post-PCR analytic method. As mRNA nucleotide sequences of the SSX1 and SSX2 segments involved in the SYT-SSX fusion are nearly identical, post-PCR methods must be highly discriminatory. We describe a novel method to identify and differentiate these two chimeric transcripts using RT-PCR followed by fluorescent thermostable ligase detection reaction (f-LDR), microparticle bead capture and flow cytometric detection. Evaluation of this unique approach in 11 cases of SS without prior knowledge of SYT-SSX status, six cases of control sarcomas (CS) and three hematopoietic cell lines, revealed that the f-LDR technique was rapid, unambiguous, and highly specific. The f-LDR results were compared to XmnI enzyme digestion patterns and sequencing of PCR products, revealing a 100% concordance for all cases of SS with regards to SYT-SSX transcript type. In addition, there was a strong association of transcript type detected by f-LDR and morphological subclassification of SS, as previously reported. We conclude that this f-LDR method with flow-based detection is a robust approach to post-PCR detection of specific nucleotide sequences in SS and may be more broadly applicable in molecular oncology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707378      PMCID: PMC1907321          DOI: 10.1016/S1525-1578(10)60462-X

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  29 in total

1.  The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.

Authors:  G Nilsson; B Skytting; Y Xie; B Brodin; R Perfekt; N Mandahl; J Lundeberg; M Uhlén; O Larsson
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

2.  Multiplexed single nucleotide polymorphism genotyping by oligonucleotide ligation and flow cytometry.

Authors:  M A Iannone; J D Taylor; J Chen; M S Li; P Rivers; K A Slentz-Kesler; M P Weiner
Journal:  Cytometry       Date:  2000-02-01

3.  Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases.

Authors:  P Argani; M F Zakowski; D S Klimstra; J Rosai; M Ladanyi
Journal:  Mod Pathol       Date:  1998-01       Impact factor: 7.842

4.  Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma.

Authors:  M van de Rijn; F G Barr; M H Collins; Q B Xiong; C Fisher
Journal:  Am J Clin Pathol       Date:  1999-07       Impact factor: 2.493

5.  Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.

Authors:  C R Antonescu; A Kawai; D H Leung; F Lonardo; J M Woodruff; J H Healey; M Ladanyi
Journal:  Diagn Mol Pathol       Date:  2000-03

6.  Needle-in-a-haystack detection and identification of base substitution mutations in human tissues.

Authors:  V L Wilson; Q Wei; K R Wade; M Chisa; D Bailey; C M Kanstrup; X Yin; C M Jackson; B Thompson; W R Lee
Journal:  Mutat Res       Date:  1999-08       Impact factor: 2.433

7.  SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.

Authors:  A Kawai; J Woodruff; J H Healey; M F Brennan; C R Antonescu; M Ladanyi
Journal:  N Engl J Med       Date:  1998-01-15       Impact factor: 91.245

8.  Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.

Authors:  S Tsuji; M Hisaoka; Y Morimitsu; H Hashimoto; S Shimajiri; S Komiya; M Ushijima; T Nakamura
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

9.  Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma.

Authors:  J Lasota; M Jasinski; M Debiec-Rychter; A Szadowska; J Limon; M Miettinen
Journal:  Mod Pathol       Date:  1998-07       Impact factor: 7.842

Review 10.  The emerging molecular genetics of sarcoma translocations.

Authors:  M Ladanyi
Journal:  Diagn Mol Pathol       Date:  1995-09
View more
  4 in total

1.  Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.

Authors:  Emily E Carmody Soni; Silke Schlottman; Hayriye V Erkizan; Aykut Uren; Jeffrey A Toretsky
Journal:  Clin Orthop Relat Res       Date:  2014-03       Impact factor: 4.176

2.  Surface-enhanced Raman scattering based ligase detection reaction.

Authors:  Yun Suk Huh; Adam J Lowe; Aaron D Strickland; Carl A Batt; David Erickson
Journal:  J Am Chem Soc       Date:  2009-02-18       Impact factor: 15.419

3.  Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.

Authors:  Hanna Majewska; Alena Skálová; Dominik Stodulski; Adéla Klimková; Petr Steiner; Czesław Stankiewicz; Wojciech Biernat
Journal:  Virchows Arch       Date:  2014-12-12       Impact factor: 4.064

4.  Mammary analogue secretory carcinoma (MASC) of salivary gland in four Mexican patients.

Authors:  Mónica L Serrano-Arévalo; Adalberto Mosqueda-Taylor; Hugo Domínguez-Malagón; Michal Michal
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.